Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
2002 7
2003 6
2004 7
2005 10
2006 2
2007 4
2008 3
2009 3
2010 2
2011 2
2012 5
2013 5
2017 2
2018 1
2019 1
2020 2
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.
Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H; LIFE Study Group. Dahlöf B, et al. Among authors: fyhrquist f. Lancet. 2002 Mar 23;359(9311):995-1003. doi: 10.1016/S0140-6736(02)08089-3. Lancet. 2002. PMID: 11937178 Clinical Trial.
Telomere length and cardiovascular aging.
Fyhrquist F, Saijonmaa O. Fyhrquist F, et al. Ann Med. 2012 Jun;44 Suppl 1:S138-42. doi: 10.3109/07853890.2012.660497. Ann Med. 2012. PMID: 22713142 Review.
Targeting the renin-angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Kjeldsen SE, Lyle PA, Tershakovec AM, Devereux RB, Oparil S, Dahlöf B, de Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Wedel H. Kjeldsen SE, et al. Among authors: fyhrquist f. Expert Opin Emerg Drugs. 2005 Nov;10(4):729-45. doi: 10.1517/14728214.10.4.729. Expert Opin Emerg Drugs. 2005. PMID: 16262560 Review.
Leucocyte telomere length in age-related macular degeneration.
Immonen I, Seitsonen S, Saionmaa O, Fyhrquist F. Immonen I, et al. Among authors: fyhrquist f. Acta Ophthalmol. 2013 Aug;91(5):453-6. doi: 10.1111/j.1755-3768.2012.02427.x. Epub 2012 May 2. Acta Ophthalmol. 2013. PMID: 22551349 Free article.
Pharmacoepigenetics of hypertension: genome-wide methylation analysis of responsiveness to four classes of antihypertensive drugs using a double-blind crossover study design.
Nuotio ML, Sánez Tähtisalo H, Lahtinen A, Donner K, Fyhrquist F, Perola M, Kontula KK, Hiltunen TP. Nuotio ML, et al. Among authors: fyhrquist f. Epigenetics. 2022 Nov;17(11):1432-1445. doi: 10.1080/15592294.2022.2038418. Epub 2022 Feb 25. Epigenetics. 2022. PMID: 35213289 Free PMC article. Clinical Trial.
Leukocyte telomere length is inversely associated with arterial wave reflection in 566 normotensive and never-treated hypertensive subjects.
Honkonen M, Vääräniemi K, Saijonmaa O, Nyman A, Tikkakoski AJ, Koskela J, Lehtimäki T, Kähönen M, Mustonen J, Fyhrquist F, Pörsti I. Honkonen M, et al. Among authors: fyhrquist f. Aging (Albany NY). 2020 Jun 23;12(12):12376-12392. doi: 10.18632/aging.103459. Epub 2020 Jun 23. Aging (Albany NY). 2020. PMID: 32575070 Free PMC article.
60 results